508 related articles for article (PubMed ID: 25261428)
1. Toxicology and management of novel psychoactive drugs.
Kersten BP; McLaughlin ME
J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428
[TBL] [Abstract][Full Text] [Related]
2. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
Coppola M; Mondola R
Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).
Dargan PI; Sedefov R; Gallegos A; Wood DM
Drug Test Anal; 2011; 3(7-8):454-63. PubMed ID: 21755604
[TBL] [Abstract][Full Text] [Related]
4. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
Liechti M
Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
[TBL] [Abstract][Full Text] [Related]
5. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
[TBL] [Abstract][Full Text] [Related]
6. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
Loeffler G; Hurst D; Penn A; Yung K
Mil Med; 2012 Sep; 177(9):1041-8. PubMed ID: 23025133
[TBL] [Abstract][Full Text] [Related]
7. Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.
Rosenbaum CD; Carreiro SP; Babu KM
J Med Toxicol; 2012 Mar; 8(1):15-32. PubMed ID: 22271566
[TBL] [Abstract][Full Text] [Related]
8. Novel Psychoactive Substances and Trends of Abuse.
Rivera JV; Vance EG; Rushton WF; Arnold JK
Crit Care Nurs Q; 2017; 40(4):374-382. PubMed ID: 28834859
[TBL] [Abstract][Full Text] [Related]
9. Analytical toxicology of emerging drugs of abuse--an update.
Meyer MR; Peters FT
Ther Drug Monit; 2012 Dec; 34(6):615-21. PubMed ID: 23131695
[TBL] [Abstract][Full Text] [Related]
10. Designer drugs 2015: assessment and management.
Weaver MF; Hopper JA; Gunderson EW
Addict Sci Clin Pract; 2015 Mar; 10(1):8. PubMed ID: 25928069
[TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
12. Novel psychoactive substances.
Krabseth HM; Tuv SS; Strand MC; Karinen RA; Wiik E; Vevelstad MS; Westin AA; Øiestad EL; Vindenes V
Tidsskr Nor Laegeforen; 2016 May; 136(8):714-7. PubMed ID: 27143461
[TBL] [Abstract][Full Text] [Related]
13. [Synthetic drugs: the new low-cost landscape of drugs].
Karila L; Petit A; Cottencin O; Coscas S; Reynaud M
Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs of abuse.
Nelson ME; Bryant SM; Aks SE
Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs of abuse: clinical and legal considerations.
Aoun EG; Christopher PP; Ingraham JW
R I Med J (2013); 2014 Jun; 97(6):41-5. PubMed ID: 24905374
[TBL] [Abstract][Full Text] [Related]
16. Re: "Spice, bath salts, and the U.S. Military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces".
Platteborze PL; Martin TM
Mil Med; 2013 Jan; 178(1):v. PubMed ID: 23356108
[No Abstract] [Full Text] [Related]
17. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
[TBL] [Abstract][Full Text] [Related]
18. The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.
Schep LJ; Slaughter RJ; Vale JA; Beasley DM; Gee P
Clin Toxicol (Phila); 2011 Mar; 49(3):131-41. PubMed ID: 21495881
[TBL] [Abstract][Full Text] [Related]
19. New drugs of abuse.
Rech MA; Donahey E; Cappiello Dziedzic JM; Oh L; Greenhalgh E
Pharmacotherapy; 2015 Feb; 35(2):189-97. PubMed ID: 25471045
[TBL] [Abstract][Full Text] [Related]
20. Khat and synthetic cathinones: a review.
Valente MJ; Guedes de Pinho P; de Lourdes Bastos M; Carvalho F; Carvalho M
Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
